Abstract: A method for manufacturing a stent includes heating a plurality of wire strands to impart a desired shape to the wire strands, coating each wire strand with a biocompatible polymer in an extruder to produce a plurality of coated wire strands, and interlacing the coated wire strands to form a stent.

Abstract: The present invention provides a tubular stent including a longitudinal cylindrical base structure having a first end portion, a second end portion, a mid-portion interposed between the first and second end portions. A plurality of linear strut members connect the mid-portion to the first and second end portions, where the first and second end portions has a first pattern and the mid portion has a second pattern different from the first pattern. The second pattern includes a plurality of articulations. Reservoirs are disposed on at least one of the first end portion, the second end portions, or the mid-portion, where the reservoirs include a pharmaceutical agent therein.

Abstract: The present invention includes a coiled wire formed of a shape memory material for implantation into an anatomical defect. After implantation of one or more of the coiled wires according to the present invention, the defect is occluded and thereby corrected or treated. Prior to implantation, the coiled wire is generally elongated and thereafter it reverts to a predetermined shape that is suitable for occluding the defect. At least one clip having at least two prongs may be provided on the wire for attachment to body tissue. Preferably the wire is made of nickel-titanium. In an alternative embodiment, the coil includes a plurality of layers. At least one of these layers is formed of a shape memory material.

Abstract: The stent has at least two different patterns along its longitudinal length such as a closed cell and an open cell design. The stent is made from nickel/titanium, titanium, stainless steel or a noble metal. The different patterns are joined by varying articulations including a W-pattern and S-pattern. The stent has at least two coatings over the base structure, the coating depth not exceeding ten microns.

Abstract: The present invention includes a coiled wire formed of a shape memory material for implantation into an anatomical defect. After implantation of one or more of the coiled wires according to the present invention, the defect is occluded and thereby corrected or treated. Prior to implantation, the coiled wire is generally elongated and thereafter it reverts to a predetermined shape that is suitable for occluding the defect. At least one clip having at least two prongs may be provided on the wire for attachment to body tissue. Preferably the wire is made of nickel-titanium. In an alternative embodiment, the coil includes a plurality of layers. At least one of these layers is formed of a shape memory material.

Abstract: The invention relates to a method of coating a surface of a stent by contacting the stent with a coating solution containing a coating material, inserting a thread through the lumen of the stent, and producing relative motion between the stent and the thread to substantially remove coating material located within the openings of the stent. Eliminating or minimizing coating material located within the openings preserves the functionality of the stent. The method can be used to apply a primer layer, a polymer, either with or without a therapeutic agent, and/or a top layer on the stent.

Abstract: The present invention relates to an implantable stent having looped ends. The stent includes a plurality of wire strands braided into a tubular structure such that the ends of the plurality of wire strands are located at a first end of the tubular structure. The stent further includes a first plurality of loops located at the first end of the tubular structure, each loop formed from a pair of ends of the plurality of wire strands. The stent further includes a second plurality of loops located at a second end of the tubular structure, each loop formed from a length of the plurality of wire strands.

Abstract: The present invention includes a coiled wire formed of a shape memory material for implantation into an anatomical defect. After implantation of one or more of the coiled wires according to the present invention, the defect is occluded and thereby corrected or treated. Prior to implantation, the coiled wire is generally elongated and thereafter it reverts to a predetermined shape that is suitable for occluding the defect. At least one clip having at least two prongs may be provided on the wire for attachment to body tissue. Preferably the wire is made of nickel-titanium. In an alternative embodiment, the coil includes a plurality of layers. At least one of these layers is formed of a shape memory material.

Abstract: Materials, devices and methods for the treatment of congestive heart failure are disclosed. In these methods, the volume of the left ventricle is reduced, thereby increasing the efficiency of the pumping action of the heart. Volume reduction is accomplished by introduction of biocompatible materials into the wall of the left ventricle, or into the ventricle itself. Suitable biocompatible materials include those that undergo a phase transition within the ventricle or within the wall of the ventricle, and are thereby converted from a substantially liquid state to a substantially solid state. Such materials also include those which increase in volume during the transition from the liquid state to the solid state. Also disclosed is a method for ventricular geometry reduction wherein flexible, elastic bands are attached to the external surface of the heart to effect a decrease in the volume of the left ventricle.

Abstract: The invention relates to a method for treating a vascular disease of a patient. The method includes identifying a disease process in the pathology of a vascular disease, selecting a therapeutic agent to treat or prevent the vascular disease, coating an intravascular implant with a therapeutically effective amount of the agent, and implanting the intravascular implant in the patient. The invention also relates to a coating for an intravascular implant to treat or prevent a vascular disease of a patient. The coating includes a therapeutically effective amount of rapamycin and a therapeutically effective amount of a second agent. The second agent is selected based on the vascular disease of the patient.

Abstract: A method for manufacturing a stent includes heating a plurality of wire strands to impart a desired shape to the wire strands, coating each wire strand with a biocompatible polymer in an extruder to produce a plurality of coated wire strands, and interlacing the coated wire strands to form a stent.

Abstract: The invention relates to a stent for implantation in a body lumen. The stent is formed from stent preforms. Each stent preform includes an elongated metal core, an outer sheath disposed about the core, and caps disposed on the ends of the outer sheath. The outer sheath and caps encapsulate the metal core to prevent the core from directly contacting the body lumen. In an alternative embodiment, an intermediate sleeve is disposed between the core and outer sheath. In another embodiment, a cover or coating may be disposed about the outer sheath.

Abstract: The present invention preferably includes a balloon catheter for use with a guidewire. The catheter has a body with a balloon located thereon, preferably at the distal end. A lumen within the catheter body communicates with the interior of the balloon which can be inflated by known methods with saline solution. A series of sleeve members of predetermined lengths and sizes are coupled to and positioned along the length of the catheter body. One or more of the sleeve members can span the length of the balloon. Each sleeve member has a passageway and both an exit and entry port so that the guidewire can pass therethrough. Instead of a balloon, the catheter can include a device member that forms a chamber which can store medicine until discharged at the desired site within the blood vessel. Apertures or pores on the catheter body allow for the perfusion of blood or the delivery of medicine to the site of the blood vessel. A method of operation is also disclosed.

Abstract: Materials, devices and methods for the treatment of congestive heart failure are disclosed. In these methods, the volume of the left ventricle is reduced, thereby increasing the efficiency of the pumping action of the heart. Volume reduction is accomplished by introduction of biocompatible materials into the wall of the left ventricle, or into the ventricle itself. Suitable biocompatible materials include those that undergo a phase transition within the ventricle or within the wall of the ventricle, and are thereby converted from a substantially liquid state to a substantially solid state. Such materials also include those which increase in volume during the transition from the liquid state to the solid state. Also disclosed is a method for ventricular geometry reduction wherein flexible, elastic bands are attached to the external surface of the heart to effect a decrease in the volume of the left ventricle.

Abstract: A balloon catheter for use with a guidewire is disclosed. The catheter has a body with a balloon located thereon, preferably at the distal end. A lumen within the catheter body communicates with the interior of the balloon which can be inflated by known methods with saline solution. A series of sleeve members of predetermined lengths and sizes are coupled to and positioned along the length of the catheter body. One or more of the sleeve members can span the length of the balloon. Each sleeve member has a passageway and both an exit and entry port so that the guidewire can pass therethrough. Instead of a balloon, the catheter can include a device member that forms a chamber which can store medicine until discharged at the desired site within the blood vessel. Apertures or pores on the catheter body allow for the perfusion of blood or the delivery of medicine to the site of the blood vessel. A method of operation is also disclosed.

Abstract: A balloon catheter for use with a guidewire is disclosed. The catheter has a body with a balloon located thereon, preferably at the distal end. A lumen within the catheter body communicates with the interior of the balloon which can be inflated by known methods with saline solution. A series of sleeve members of predetermined lengths and sizes are coupled to and positioned along the length of the catheter body. One or more of the sleeve members can span the length of the balloon. Each sleeve member has a passageway and both an exit and entry port so that the guidewire can pass therethrough. Instead of a balloon, the catheter can include a device member that forms a chamber which can store medicine until discharged at the desired site within the blood vessel. Apertures or pores on the catheter body allow for the perfusion of blood or the delivery of medicine to the site of the blood vessel. A method of operation is also disclosed.

Abstract: A stent is made from multiple wire strands coated with a biocompatible fluoropolymer. A knitting or braiding machine receives a plurality of the coated wire strands from spools and interlaces them into a tubular stent. The coated wire strand is made of materials such as stainless steel, tungsten, titanium, nickel titanium alloy (NITINOL®) gold or silver. The wire can be heat set prior to coating with the fluoropolymer. The resulting stent is tubular in shape and has a uniform porosity around each interlaced coated wire component.

Abstract: The invention relates to a coating for an intravascular implant that prevents hyperproliferative vascular disease after a mechanical injury, such as angioplasty. The coating includes first and second agents, with the first agent acting on a calcium independent cellular pathway and the second agent acting on a calcium dependent cellular pathway. In an exemplary embodiment, the first agent is rapamycin and the second agent is cyclosporine A. The agents can be incorporated in a polymeric agent and can be applied either directly to the implant or on top of a primer layer placed on the implant. A top coat can be applied to the therapeutic coating, if desired.

Abstract: A balloon catheter for use with a guidewire is disclosed. The catheter has a body with a balloon located thereon, preferably at the distal end. A lumen within the catheter body communicates with the interior of the balloon which can be inflated by known methods with saline solution. A series of sleeve members of predetermined lengths and sizes are coupled to and positioned along the length of the catheter body. One or more of the sleeve members can span the length of the balloon. Each sleeve member has a passageway and both an exit and entry port so that the guidewire can pass therethrough. Instead of a balloon, the catheter can include a device member that forms a chamber which can store medicine until discharged at the desired site within the blood vessel. Apertures or pores on the catheter body allow for the perfusion of blood or the delivery of medicine to the site of the blood vessel. A method of operation is also disclosed.

Abstract: The invention relates to a method of coating a surface of a stent by contacting the stent with a coating solution containing a coating material, inserting a thread through the lumen of the stent, and producing relative motion between the stent and the thread to substantially remove coating material located within the openings of the stent. Eliminating or minimizing coating material located within the openings preserves the functionality of the stent. The method can be used to apply a primer layer, a polymer, either with or without a therapeutic agent, and/or a top layer on the stent.